704 filings
8-K
EVFM
Evofem Biosciences, Inc.
28 Mar 24
Regulation FD Disclosure
5:11pm
10-K
2023 FY
EVFM
Evofem Biosciences, Inc.
Annual report
27 Mar 24
8:40am
8-K
EVFM
Evofem Biosciences, Inc.
27 Mar 24
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023
8:36am
8-K
EVFM
Evofem Biosciences, Inc.
6 Mar 24
Entry into a Material Definitive Agreement
5:14pm
SC 13G/A
EVFM
Evofem Biosciences, Inc.
14 Feb 24
Evofem Biosciences / CVI Investments ownership change
2:14pm
8-K
EVFM
Evofem Biosciences, Inc.
1 Feb 24
Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
9:05am
8-K
EVFM
Evofem Biosciences, Inc.
31 Jan 24
Entry into a Material Definitive Agreement
4:26pm
8-K/A
EVFM
Evofem Biosciences, Inc.
25 Jan 24
Financial Statements and Exhibits
4:23pm
4
Yan Zhang
12 Jan 24
Evofem Biosciences / Yan Zhang ownership change
5:13pm
8-K
EVFM
Evofem Biosciences, Inc.
11 Jan 24
Entry into a Material Definitive Agreement
4:53pm
8-K
EVFM
Evofem Biosciences, Inc.
26 Dec 23
Entry into a Material Definitive Agreement
5:37pm
4
EVFM
Evofem Biosciences, Inc.
22 Dec 23
Evofem Biosciences / Kim P. Kamdar ownership change
4:05pm
8-K
EVFM
Evofem Biosciences, Inc.
12 Dec 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EVFM
Evofem Biosciences, Inc.
7 Dec 23
Entry into a Material Definitive Agreement
4:05pm
10-Q
2023 Q3
EVFM
Evofem Biosciences, Inc.
Quarterly report
14 Nov 23
12:00am
8-K
EVFM
Evofem Biosciences, Inc.
14 Nov 23
Evofem Biosciences Announces Financial Results for the Third Quarter of 2023
12:00am
8-K
EVFM
Evofem Biosciences, Inc.
24 Oct 23
Evofem Biosciences Announces Preliminary Results for the Third Quarter of 2023
7:40am
D
EVFM
Evofem Biosciences, Inc.
10 Oct 23
$2.88 mm in debt / options / securities to be acquired, sold $2.88 mm, 14 investors
7:57pm
8-K
EVFM
Evofem Biosciences, Inc.
3 Oct 23
Entry into a Material Definitive Agreement
4:07pm
8-K
EVFM
Evofem Biosciences, Inc.
27 Sep 23
Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi Until Evofem’s Phexxi Patents Expire
8:50am